Our MEA technology is on the forefront of organoid research.
Neuroscience research is about to change – and Multi Channel Systems is already adapting our MEA solutions to meet your lab’s needs for 3D multielectrode array systems.
Commercial availability of 3D MEA systems
Organoids are now FDA-approved for drug screening, clearing the way for new MEA technologies, as well as cost savings and a reduction in animal usage for researchers. But current multielectrode array solutions fall short: though it’s possible to record data from an organoid with a traditional 2D MEA chip, collapsing and flattening of the organoid structure is inevitable, which could compromise data. Other solutions, such as needle MEAs, harm the organoid. At Harvard Bioscience, a 3D MEA solution is close on the horizon, and we’re preparing to be the first MEA company to launch a commercially available 3D mesh MEA chip that allows for recording of data from inside the organoid without damage to the interior or external structure.
Contact us to learn more about our organoid research solutions and our upcoming 3D MEA solution.